Safety and effectiveness of sorafenib in Japanese patients with hepatocellular carcinoma in daily medical practice: interim analysis of a prospective postmarketing all-patient surveillance study
Crossref DOI link: https://doi.org/10.1007/s00535-016-1173-5
Published Online: 2016-03-01
Published Print: 2016-10
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kaneko, Shuichi
Ikeda, Kenji
Matsuzaki, Yasushi
Furuse, Junji
Minami, Hironobu
Okayama, Yutaka
Sunaya, Toshiyuki
Ito, Yuichiro
Inuyama, Lyo
Okita, Kiwamu
Funding for this research was provided by:
Bayer Yakuhin, Ltd.
License valid from 2016-03-01